ESHG 2019

15 JUNE 2019 18 JUNE 2019

Roche Sequencing invites you to ESHG, Booth # 552  

Join us at the 2019 European Society of Human Genetics (ESHG) Annual Meeting, where we will introduce you to our growing Sequencing portfolio – the AVENIO Tumor Tissue Kit* , the new NAVIFY Mutation Profiler and our always evolving Roche Sample Prep Solutions – which includes new KAPA Unique Dual-Indexed Adapters* ,and our soon-to-launch KAPA HyperPure Beads*.

Join us at our Corporate Satellite Event:  

NGS in Oncology today – Pain Points and Solutions


Monday, June 17, 11:15 – 12:45 in Conference room A-3  

Host: Maximilian Schmid, MD,

Head of Medical Affairs Roche Sequencing Solutions, Inc.  


Blood-based therapy monitoring in lung adenocarcinoma

Holger Sültmann, PhD
Professor of Applied Genome Research
Head of Cancer Genome Research Group
German Cancer Research Center and National Center for Tumor Diseases
Heidelberg, Germany

Practical experience as a pilot with the NAVIFY Mutation Profiler - a pragmatic voice from the bridge deck

Markus Tiemann, MD
CEO and Managing Director
Institute of Hematopathology
Hamburg, Germany

Oncology NGS: Dreams Delivered?

Marianne Nicolson, MD
Professor of Medical Oncology,
Aberdeen University,
Aberdeen Royal Infirmary, UK


If you are not attending ESHG and would like to learn more about these topics, please contact your local Roche representative.

*For Research Use Only. Not for use in diagnostic procedures.

KAPA, MAGNA PURE and NAVIFY are trademarks of Roche. All other product names and trademarks are the property of their respective owners.

This email is sent by ESHG on behalf of sponsors, exhibitors or organisers of satellite symposia in order not to disclose your email address to these companies or organisations. The ESHG does not endorse the content of this mailing. Subjects of satellite symposia were reviewed and approved by the Scientific Programme Committee, however the detailed content is proposed directly by the sponsor and is under their responsibility.